Section Arrow
Quote
CPRX.NASDAQ
- Catalyst Pharmaceuticals
Quotes are at least 15-min delayed:2024/12/24 12:38 EST
Last
 21.6
0 (0.00%)
Day High 
21.635 
Prev. Close
21.6 
1-M High
23.02 
Volume 
152.46K 
Bid
21.59
Ask
21.61
Day Low
21.35 
Open
21.54 
1-M Low
20.93 
Market Cap 
2.58B 
Currency USD 
P/E 18.25 
%Yield -- 
10-SMA 21.62 
20-SMA 21.77 
50-SMA 21.76 
52-W High 24.27 
52-W Low 13.1161 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.18/1.99
Enterprise Value
2.58B
Balance Sheet
Book Value Per Share
5.54
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
398.20M
Operating Revenue Per Share
2.92
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.3881-0.015-3.72%-- 
CMNDClearmind Medicine1.6205+0.4005+32.83%0.16PE
CEROCERo Therapeutics Holdings0.0596+0.0091+18.02%-- 
RXRXRecursion Pharmaceuticals7.1901+0.2001+2.86%-- 
CDTConduit Pharmaceuticals0.058125+0.003625+6.65%-- 
Quotes are at least 15-min delayed：2024/12/24 12:38 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.